News

October 8, 2013

OBI Pharma Announces NT$ 1.5 Billion Capital Infusion

[…]
July 26, 2013

OBI Pharma Wins the “Greatest Potential Award” at the 2013 Outstanding Biotech Awards

[…]
February 7, 2013

OBI Pharma re-elects its board of directors and supervisors, and selects a new chairman of the board.

[…]
January 31, 2013

OBI Pharma to launch Phase 1 clinical trial for a new generation of carbohydrate cancer immunotherapy in 2014.

[…]